JZA70
Banned
- Reaction score
- 59
RepliCel Life Sciences Inc. a clinical stage regenerative medicine company focused on the development of autologous cell therapies, is pleased to announce that its RCH-01 licensing partner, Shiseido, celebrated the opening of its new cell-processing facility at the Kobe Biomedical Innovation Cluster (KBIC) located on Port Island, Japan on May 18, 2014. Dignitaries, physicians, partner companies, and government representatives were in attendance at this important event. Shiseido's state-of-the-art facility will focus on the continued research and development, and the commercialization of RepliCel's RCH-01 hair regeneration technology.
http://www.marketwatch.com/story/re...1-a-treatment-for-pattern-baldness-2014-05-20
http://www.marketwatch.com/story/re...1-a-treatment-for-pattern-baldness-2014-05-20